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Abstract Inpost-genomicbiology,high-throughputanalysistechniquesallowalargenum-
ber of genes and gene products to be studied simultaneously. These techniques
are embedded in experimental pipelines that produce high volumes of data at
various stages. Ultimately, the biological interpretation derived from the data
analysis yields publishable results. Their quality, however, is routinely affected
by the number and complexity of biological and technical variations within the
experiments, both of which are difﬁcult to control.
In this chapter we present an analysis of some of these issues, conducted
through a survey of quality control techniques within the speciﬁc ﬁelds of tran-
scriptomicsandproteomics. Ouranalysissuggeststhat, despitetheirdifferences,
a common structure and a common set of problems for the two classes of exper-
iments can be found, and we propose a framework for their classiﬁcation. We
argue that the scientists’ ability to make informed decisions regarding the quality
ofpublisheddatareliesontheavailabilityofmeta-informationdescribingtheex-
periment variables, as well as on the standardization of its content and structure.
Information management expertise can play a major role in the effort to model,
collect and exploit the necessary meta-information.
Keywords: Information quality, quality control, transcriptomics, proteomics.
1. MOTIVATION
With several genomes of model organisms now being fully sequenced and
withtheadventofhigh-throughputexperimentaltechniques,researchinbiology
is shifting away from the study of individual genes, and towards understanding
complex systems as a whole, an area of study called systems biology (Ideker
et al., 2001). Instead of studying one gene or protein at a time, a large number
of genes or proteins are monitored simultaneously. Different kinds of experi-
mental data are integrated and analyzed to draw biological conclusions, state
newhypotheses,andultimatelygeneratemathematicalmodelsofthebiological
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A single high-throughput experiment may generate thousands of measure-
ments, requiring the use of data-intensive analysis tools to draw biologically
signiﬁcant conclusions from the data. The data and its biological interpreta-
tion are then disseminated through public repositories and journal publications.
Oncepublished,itcanbeusedwithinthescientiﬁccommunitytoannotategene
and protein descriptions in public databases, and to provide input to so-called
in silico experiments, i.e., “procedures that use computer-based information
repositoriesandcomputationalanalysistoolstotestahypothesis, deriveasum-
mary, search for patterns, or demonstrate a known fact” (Greenwood et al.,
2003).
In the recent past, research into the quality of information available in public
biology databases has been focusing mainly on the issue of data reconcilia-
tion across multiple and heterogeneous data sources (Lacroix and Critchlow,
2004; Rahm, 2004). In this area, it has been possible to adapt techniques and
algorithms for which a largely domain-independent theoretical framework ex-
ists, notably for record linkage (Winkler, 2004) and for data integration in the
presence of inconsistencies and incompleteness (Naumann et al., 2004; Motro
et al., 2004).
Data reconciliation techniques, however, largely fail to address the basic
problem of establishing the reliability of experimental results submitted to a
repository, regardless of their relationships with other public data. This is a
fundamental and pervasive information quality problem1: using unproven or
misleading experimental results for the purpose of database annotation, or as
input to further experiments, may result in wrong scientiﬁc conclusions. As we
will try to clarify in this chapter, techniques and, most importantly, appropriate
meta-data for objective quality assessment are generally not available to scien-
tists,whocanbeonlyintuitivelyawareoftheimpactofpoorqualitydataontheir
own experiments. They are therefore faced with apparently simple questions:
are the data and their biological implications credible? are the experimental
results sound, reproducible, and can they be used with conﬁdence?
This survey offers an insight into these questions, by providing an introduc-
tory guide for information management practitioners and researchers, into the
complex domain of post-genomic data. Speciﬁcally, we focus on data from
transcriptomics and proteomics, i.e., the large-scale study of gene2 and protein
expression, which represent two of the most important experimental areas of
the post-genomic era.
We argue that answering the scientists’ questions requires a thorough un-
derstanding of the processes that produce the data, and of the quality control
measures taken at each step in the process. This is not a new idea: a gener-
ally accepted assumption in the information quality community (Ballou et al.,
1998; Wang, 1998) has been to consider information as a product, created by a
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ity control used in manufacturing could be adapted for use with data. These
ideas have been embedded into guidelines for process analysis that attempt to
ﬁnd metrics for measuring data quality (English, 1999; Redman, 1996).
While we subscribe to this general idea, we observe that an important dis-
tinction should be made between business data, to which these methodologies
have been applied for the most part (with some exceptions: see, e.g., (Mueller
et al., 2003) for an analysis of data quality problems in genome data), and
experimental scientiﬁc data. Business data is often created in few predictable
ways, i.e., with human input or input from other processes (this is the case, e.g.,
in banking, public sector, etc.), and it has a simple interpretation (addresses,
accounting information). Therefore, traditional data quality problems such as
staledata,orinconsistenciesamongcopies,canoftenbetracedtoproblemswith
theinputchannelsandwithdatamanagementprocesseswithinthesystems,and
software engineering techniques are usually applied to address them.
The correct interpretation of scientiﬁc data, on the other hand, requires a
precise understanding of the broad variability of the experimental processes
that produce it. With research data in particular, the processes are themselves
experimentalandtendtochangerapidlyovertimetotracktechnologyadvances.
Furthermore,existingqualitycontroltechniquesareveryfocusedonthespeciﬁc
data and processes, and are difﬁcult to generalize; hence the wealth of domain-
speciﬁc literature offered in this survey.
This variability and complexity makes the analysis of quality properties for
scientiﬁcdatadifferentandchallenging. Inthisdomain, traditionaldataquality
issuessuchascompleteness,consistency,andcurrencyaretypicallyobservedat
the end of the experiment, when the ﬁnal data interpretation is made. However,
as the literature cited in this chapter shows, there is a perception within the
scientiﬁc community that quality problems must be addressed at all the stages
of an experiment.
For these reasons, we focus on the data creation processes, rather than on the
maintenance of the ﬁnal data output. We concentrate on two classes of experi-
ments, microarray data analysis for transcriptomics, and protein identiﬁcation
for proteomics. In these areas, the quality of the data at the dissemination stage
is determined by factors such as the intrinsic variability of the experimental
processes, both biological and technical, and by the choice of bioinformatics
algorithms for data analysis; these are often based on statistical models and
their performance is in turn affected by experimental variability, among other
factors. A brief background on these technologies is provided in Section 2.
As a matter of method, we observe that these two classes can be described
usingthesamebasicsequenceofsteps,andthatthecorrespondingqualityprob-
lemsalsofallintoasmallnumberofcategories. Weusetheresultingframework
to structure a list of domain-speciﬁc problems, and to provide references for
the techniques used to tackle them. This analysis is presented in Section 3.66 DATABASE MODELING IN BIOLOGY: PRACTICES AND CHALLENGES
Althoughthequalitycontroltechniquessurveyedarerootedinthecontextof
post-genomics,andthissurveydoesnotdiscussspeciﬁctechniquesorsolutions
in depth, a few general points emerge from this analysis regarding technical
approaches to quality management. Firstly, the importance of standards for
accurately modelling and capturingprovenance meta-data regarding the exper-
iments, i.e., details of the experimental design and of its execution. Secondly,
the standardization of their representation, in order to deal with heterogeneity
among different laboratories that adopt different experimental practices. These
points are discussed in Section 4.
Afurtherpotentiallypromisingcontributionofferedbytheinformationqual-
ity community is the study of information as a product, already mentioned
(Ballou et al., 1998; Wang, 1998). However, to the best of our knowledge, no
general theory of process control for these data domains has been developed.
2. THE EXPERIMENTAL CONTEXT
We describe the general steps of a rather generic biological experiment,
starting from the experimental design, leading to a publication, and further,
to the use of published literature for the functional annotation of genes and
proteins in databases. An overview of this abstraction is shown in Figure 4.1.
Figure 4.1. Sample high-throughput biological data processing pipeline
The experiment begins with the statement of a scientiﬁc hypothesis to be
tested; along with constraints imposed by the laboratory equipment, this leads
to the choice of an appropriate experimental design. The so-called wet lab
portionisexecutedbythebiologist, startingfromthepreparationofthesample,
and usually leading to the generation of some form of raw data.
It is common to build elements of repetition into the experiment, to take
into account both technical and biological variability, speciﬁcally: (i) Techni-
cal repeats: After preparation, the sample is divided into two or more portions
and each portion is run through exactly the same technical steps, leading to
separate measurements for each portion. This is done to account for the vari-
abilityofthetechnicalprocess; (ii)Biologicalrepeat: Twoormoresamplesare
obtained from different individuals studied under exactly the same conditions.
These samples are then prepared using the same protocol and run through the
same technical process. These repeats allow for the estimation of biological
variability between individuals.Information Quality Management Challenges for High-throughput Data 67
The raw data generated in the lab is then analyzed in the so-called dry lab, a
computing environment equipped with a suite of bioinformatics data analysis
tools. The processed data is then interpreted in the light of biological knowl-
edge, and scientiﬁc claims can be published. A growing number of scientiﬁc
journalsexplicitlyrequirethattheexperimentaldatabesubmittedtopublicdata
repositories at the same time (Editors, 2002).
The result of data analysis and interpretation is processed data, which can
include not only the experimental data in analyzed form, but also additional
information that has been used to place the data into context, such as the func-
tional annotation of genes and proteins or pathways the proteins are involved
in.
The repetition of this process for a large number of high-throughput experi-
ments and over a period of time results in a body of literature about a particular
gene or protein. This knowledge is used by curators as evidence to support the
annotation of genes and proteins described in public databases, such as MIPS
(Mewes et al., 2004) and Swiss-Prot (Apweiler et al., 2004). A protein annota-
tion typically includes a description of its function, of the biological processes
in which it participates, its location in the cell, and its interactions with other
proteins.
Reaching conclusions regarding protein function requires the analysis of
multiplepiecesofevidence,theresultsofmanyexperimentsofdifferentnatures,
and may involve a combination of manual and automated steps (Bairoch et al.,
2004). Inthischapter,weconcentrateontwoclassesofexperiments,microarray
analysis of gene expression and protein identiﬁcation; they share the general
structureoutlinedabove,andarerelevantfortheircontributiontotheknowledge
used by the curation process.
We now brieﬂy review some deﬁnitions regarding these experiments.
2.1 Transcriptomics
Transcriptome experiments use microarray technology to measure the level
of transcription of a large number of genes (up to all genes in a genome) si-
multaneously, as an organism responds to the environment. They measure the
quantity of mRNA produced in response to some environmental factor, for in-
stance some treatment, at a certain point in time, by obtaining a snapshot of the
gene activity at that time3.
Here we only provide a brief introduction to the experimental steps involved
and the data analysis. For recent reviews on this topic, see (Lockhart and
Winzeler, 2000; Bowtell, 1999; Holloway et al., 2002). In addition, (Bolstad
et al., 2004; Quackenbush, 2001; Leung and Cavalieri, 2003) provide reviews
of methods to normalize and analyze transcriptome data.
An array is a matrix of spots, each populated during manufacturing with
known DNA strands, corresponding to the genes of interest for the experiment.68 DATABASE MODELING IN BIOLOGY: PRACTICES AND CHALLENGES
When a sample consisting of mRNA molecules from the cells under investi-
gation is deposited onto the array, these molecules bind, or hybridize, to the
speciﬁc DNA templates from which they originated. Thus, by looking at the
hybridized array, the quantity of each different mRNA molecule of interest that
was involved in the transcription activity can be measured.
Among the many different array technologies that have become available
within the last few years, we focus on the most common two, cDNA (Cheung
et al., 1999) and oligonucleotide arrays (Lipshutz et al., 1999). The choice
between the two is dictated by the available equipment, expertise, and by the
type of experiment: an oligonucleotide array accepts one sample, and is suit-
able for measuring absolute expression values, whereas cDNA arrays accept
twosamples, labeledusingtwodifferentﬂuorescentdyes, whichmayrepresent
the state of the organism before and after treatment; they are used to measure
ratios of expression levels between the two samples. To obtain ratios using
oligonucleotide technology two arrays are necessary, and the ratios are com-
puted from the separate measurements of each. This difference is signiﬁcant,
because the technical and biological variability of these experiments play a role
in the interpretation of the results.
The measurements are obtained by scanning the arrays into a digital image,
which represents the raw data from the wet lab portion of the experiment. In
the dry lab, the image is analyzed to identify poor quality spots, which are
excluded from further analysis, and to convert each remaining spot into an
intensity value (the “raw readings” in Figure 4.2). These values are normalized
to correct for background intensity, variability introduced in the experiment,
and also to enable a comparison between repeats.
In the subsequent high-level data analysis, the normalized data is interpreted
in the light of the hypothesis stated and the biological knowledge, to draw
publishable conclusions. Typically, the goal of the analysis is to detect genes
that are differentially expressed after stimulation, or to observe the evolution
of expression levels in time, or the clustering of genes with similar expression
patterns over a range of conditions and over time. Statistical and machine
learning approaches are applied in this phase (Kaminski and Friedman, 2002;
Dudoit et al., 2000; Quackenbush, 2001).
Each of these process steps involves choices that must be made (e.g., of
technology, of experiment design, and of low-level and high-level data analysis
algorithms and tools), which are inter-dependent and collectively affect the
signiﬁcance of the ﬁnal result. We survey some of these factors in the next
section.
2.2 Qualitative Proteomics
The term proteomics refers to large-scale analysis of proteins, its ultimate
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investigation. Here we only consider the problem of identifying the proteins
withinasample, aproblemofqualitativeproteomics; thisinvolvesdetermining
the peptide masses and sequences of the proteins present in a sample, and
matching those against theoretically derived peptides calculated from protein
sequencedatabases. Forin-depthreviewsoftheﬁeld,see(AebersoldandMann,
2003; Pandey and Mann, 2000; Patterson and Aebersold, 2003).
This technology is suitable for experiments in which the protein contents
before and after a certain treatment are compared, ultimately leading to con-
clusions regarding their function, the biological processes in which they are
involved, andtheirinteractions. Themainstepsoftheexperimentalprocessare
shown at the bottom part of Figure 4.2.
A sample containing a number of proteins (possibly of the order of thou-
sands) undergoes a process of separation, commonly by two-dimensional elec-
trophoresis(2DE),resultingintheseparationoftheproteinsontoagelbasedon
two orthogonal parameters, their charge and their mass. The separated proteins
spotted on the gel are then excised and degraded enzymatically to peptides.
An alternative technique for peptide separation involves liquid chromatogra-
phy (LC) (see (Hunter et al., 2002; de Hoog and Mann, 2004) for reviews). LC
is used to purify and separate peptides in complex peptide mixtures and can
be used without the extra step of protein separation on a gel before digestion
(Pandey and Mann, 2000). Peptides are separated by their size, charge, and
hydrophobicity.
To identify the proteins mass spectrometry (MS) is used to measure the
mass-to-charge ratio of the ionized peptides. The spectrometer produces mass
spectra, i.e., histograms of intensity vs. mass/charge ratio. For single-stage
experiments, these are called peptide mass ﬁngerprints (PMF). Additionally, a
selectionofthesepeptidescanbefurtherfragmentedtoperformtandemMS,or
“MS/MS” experiments, which generate spectra for individual peptides. From
these spectra the sequence tag of the peptide can be derived. Using sequence
information of several peptides in addition to their masses is more speciﬁc for
the protein identiﬁcation than just the masses.
The key parameters for this technology are sensitivity, resolution, and the
ability to generate information-rich mass spectra. The issue of resolution arises
when one considers that every cell may express over 10,000 genes, and that the
dynamic range of abundance in complex samples can be as high as 106. Since
2DE technology can resolve no more than 1,000 proteins, clearly only the most
abundant proteins can be identiﬁed, which creates a problem when interesting
proteins are much less abundant (Pandey and Mann, 2000). Techniques have
beendevelopedtodealwiththeseissues(Floryetal.,2002);ingeneral,however,
limitations in the technology translate into inaccuracies in the resulting spectra.
Finally, in the dry lab the mass spectra are compared with masses and se-
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more choices: a number of different algorithms, e.g., Mascot (Perkins et al.,
1999), SEQUEST (Eng et al., 1994), exist to compute a score for the good-
ness of the match between the theoretical peptide sequences in the database
and the experimental data. Also, these algorithms may be applied to differ-
ent reference databases, and provide different indicators to assess the quality
of the match. Examples of indicators are the hit ratio (the number of peptide
masses matched, divided by the total number of peptide masses submitted to
the search), and the sequence coverage (the percentage of the number of amino
acids in the experimental sequence, to those in the theoretical sequence).
The quality of the scoring functions in particular is affected by experimental
variability, and statistical and computational methods have been proposed to
deal with the uncertainty of the identiﬁcation process (see (Sadygov et al.,
2004) for a review, as well as the references in Table 4.3).
3. A SURVEY OF QUALITY ISSUES
We begin our analysis by presenting a common framework, illustrated in
Figure 4.2. At the top and the bottom are the main steps of the protein identiﬁ-
cation and of the microarray experiments, respectively. The ﬁgure shows their
common structure in terms of the general wet lab, dry lab, and dissemination
steps, and highlights the key quality concerns addressed by experimenters at
each step. We use this high-level framework to provide structure for the analy-
sis of domain-speciﬁc issues, and the current techniques and practices adopted
to address them.
In Section 3.4, a separate discussion is devoted to the problem of annotating
information after it has been submitted to proteomic databases; this has only
been addressed in the past by relatively few and isolated experiments.
3.1 Variability and experimental design
Both transcriptome and proteome experiments consist of a number of steps,
each of which can introduce factors of variability. However, it is not only
the variability introduced in the experimental process (the so called technical
variability) that can affect the quality of the results, but also biological variabil-
ity. Systematic analyzes of variability in transcriptome studies (Bakay et al.,
2002; Yang and Speed, 2002) and proteome studies (Molloy et al., 2003) have
shown that biological variability may have a greater impact on the result.
Biological variability
Thisformofvariabilityaffectstheresultsofbothtranscriptomeandproteome
experiments, it is of rather random nature and is hard to estimate. Examples
include: (i) variability between individuals studied under the same experimen-
tal condition (Novak et al., 2002; Bakay et al., 2002) due to genetic differencesInformation Quality Management Challenges for High-throughput Data 71
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(Molloy et al., 2003), minor infections resulting in inﬂammatory and immune
responses of varying intensities (Yang and Speed, 2002), environmental stress,
or different activity levels, but can also be due to tissue heterogeneity (varying
distribution of distinct cell types in tissues); (ii) variability between individuals
due to random differences in the experimental conditions, such as growth, cul-
ture, or housing conditions (Hatﬁeld et al., 2003; Novak et al., 2002; Molloy
et al., 2003); (iii) variability within individuals and within the same tissue due
to tissue heterogeneity (Bakay et al., 2002; Leung and Cavalieri, 2003); (iv)
variability within individuals in different tissues or cell types (Hatﬁeld et al.,
2003). Inthiscasethedifferencesaremoredistinctthanwithinthesametissue.
These variabilities can obscure the variation induced by the stimulation of
the organism (Novak et al., 2002), leading to results meaningless in the context
of the stated hypothesis. Biological variability can be addressed in part at the
early stages by proper experimental design, for example by a sufﬁcient number
of biological repeats (Bolstad et al., 2004; Novak et al., 2002; Yang and Speed,
2002) that can be used to average over the data and validate the conclusions
over a range of biological samples. For further validation of the results, they
should be conﬁrmed using alternative experimental techniques on a number of
biological samples (Novak et al., 2002).
Technical variability
This usually represents some kind of systematic error or bias introduced
in the experimental process and once known can be corrected for in the data
analysis, such as normalization. It can also be reduced by appropriate exper-
imental design. Examples are mentioned in Table 4.1. To reduce technical
variability, experimental protocols that result in reproducible, reliable results
can be identiﬁed and then followed meticulously (Novak et al., 2002). Dye
swap cDNA microarray experiments, in which the labeling dye of the samples
is reversedin the repeat (Leung and Cavalieri, 2003; Kerrand Churchill, 2001),
are used to account for dye-based bias. To estimate the inﬂuence of technical
variability on results of both transcriptome and proteome experiments, techni-
cal repeats can be used (Bolstad et al., 2004; Novak et al., 2002; Leung and
Cavalieri,2003;Molloyetal., 2003). Formulaehavebeendevisedtodetermine
thenumberofrepeatsandsamplesbytakingintoaccounttheeffectsofpooling,
technical replicates, and dye-swaps (Dobbin and Simon, 2005).
Experimental design
Experimental design not only includes the decision about the number of bi-
ological and technical replicates, it also includes all the decisions about sample
preparation methods, experimental techniques and data analysis methods. All
these decisions should be made to ensure that the data collected in the experi-
ment will provide the information to support or reject the scientiﬁc hypothesis.Information Quality Management Challenges for High-throughput Data 73
Table 4.1. Examples of technical variability introduced in transcriptomics and proteomics
Wet lab Dry lab
Sample preparation Experimental process Data analysis
Variation in sample collection and
preparation
Variation in experimental data col-
lection processes
Variation in data processing and
analysis
Transcriptomics
² RNA extraction and labeling
(van Bakel and Holstege, 2004;
Bakay et al., 2002; Bolstad et al.,
2004; Hatﬁeld et al., 2003; No-
vak et al., 2002). Variability in
the sample preparation can result
in change of the gene expression
proﬁle.
² Sample contamination (Leung
and Cavalieri, 2003).
² Dye-based bias, i.e., one dye
might be ‘brighter’ than the other
dye(KerrandChurchill, 2001;Le-
ung and Cavalieri, 2003).
² Variation in hybridization
process (van Bakel and Holstege,
2004; Bolstad et al., 2004; Hat-
ﬁeld et al., 2003; Novak et al.,
2002; Yang and Speed, 2002).
Variations introduced in the
process can obscure changes
caused by the stimulation of
the organism, i.e., changes that
the experiment actually seeks to
determine.
² Different data processing ap-
proaches (van Bakel and Holstege,
2004; Hatﬁeld et al., 2003). The
wide range of available analysis
approaches make it hard to assess
the performance of each of them
and to compare the results of ex-
periments carried out in different
labs.
Proteomics
²Variabilityinsamplepreparation
andprocessingforLC/MS/MScan
lead to differences in the number
of low intensity peaks measured
(Stewart et al., 2004). This can re-
sult in the identiﬁcation of fewer
peptides and proteins.
² Variability in tandem mass spec-
tra collection (LC/MS/MS) (Ven-
able and Yates, III, 2004; Stew-
art et al., 2004). Variability in-
troduced here can lead to errors in
searchalgorithmsandultimatelyto
false positives in peptide identiﬁ-
cation.
² Quantitative variation between
matched spots in two 2D-gels and
fewer spots that can be matched in
repeatedgels(Molloyetal.,2003).
² Variability in tandem mass spec-
tra processing (LC/MS/MS) (Ven-
able and Yates, III, 2004; Stew-
art et al., 2004). Some of the
search algorithms used to iden-
tify peptides might be more or
less sensitive to the variability in-
troduced during the collection of
mass spectra (Venable and Yates,
III, 2004), resulting in a different
number of identiﬁed peptides in
thesamespectrausingdifferental-
gorithms.
Badly designed experiments might not only not provide the answers to the
questions stated, but might also leave potential bias in the data that might com-
promise the analysis and interpretation of the result (Yang and Speed, 2002).
Reviews of experimental design of transcriptome and proteome experiments
can be found in (Kerr and Churchill, 2001; Yang and Speed, 2002; Bolstad
et al., 2004; Riter et al., 2005).
The number of variabilities that affect the outcome of an experiment make
it hard to assess its quality. As we argue in the next section, an accurate record
of the experimental design and of the environmental variables involved is a
necessary, but hardly sufﬁcient, condition to provide objective indicators that
can be used to assess conﬁdence in the experimental results.
3.2 Analysis of quality issues and techniques
Results of our survey analysis are presented in Tables 4.2 and 4.3 for tran-
scriptomics and proteomics experiments, respectively. Each group of entries
correspondstooneofthegeneralqualityconcernsfromFigure4.2(ﬁrstcolumn74 DATABASE MODELING IN BIOLOGY: PRACTICES AND CHALLENGES
in the table); for each group, speciﬁc problems are listed in the third column,
and a summary of associated current practices and techniques including ex-
amples that illustrate the need to address the issues using those practices and
techniques follows in the last column. An additional grouping of these issues
by type of artifact produced during the process (second column) is provided
where appropriate. For instance, “repeatibility and reproducibility” (second
group) in Table 4.2 maps to two problems, of general adequacy of the process
description for future reference, and of control of variability factors. For the
latter, the issues are sufﬁciently distinct to suggest grouping them by artifact
(hybridized array, raw data, interpretation of normalized data).
These tables, along with the selected references associated to the entries, are
designed as a sort of “springboard” for investigators who are interested in a
deeper understanding of the issues discussed in this chapter.
Qualityissuesthatarenotaddressedintheprocessoftheexperimentmayre-
sultinpoordataqualityinformoffalsepositivesorfalsenegativesandmaylead
to incorrect conclusions. As these high-throughput experiments are frequently
used not only to test hypotheses, but due to their scale also to generate new
hypotheses, these new hypotheses might be wrong and follow-up experimental
expenses and time to test these hypotheses may be wasted.
3.3 Speciﬁcity of techniques and generality of quality
dimensions
Most of the techniques mentioned in the tables, on which we will not elab-
orate due to space constraints, are speciﬁc and difﬁcult to generalize into a
reusable “quality toolkit” for this data domain. While this may be frustrating to
some quality practitioners in the information systems domain, we can still use
some of the common terms for quality dimensions, provided that we give them
a correct interpretation. A good example is the deﬁnition of “accuracy”: in its
generality, it is deﬁned as the distance between a data value and the real value.
When applied to a record or a ﬁeld in a relational database table, this deﬁnition
is specialized by introducing distance functions that measure the similarity be-
tween the value in the record and a reference value, for instance by computing
the edit distance between strings. Further distinctions are made depending on
the type of similarity that we seek to measure.
In the experimental sciences, the abstract deﬁnition for accuracy is identical
(see for instance (van Bakel and Holstege, 2004)), however for a value that rep-
resents the numeric output of an experimental process, accuracy is interpreted
in statistical terms, as a measure of systematic error, e.g., background noise
in the experiment. Consequently, techniques for estimating accuracy, i.e., the
equivalent of “distance functions”, are grounded in the nature of the process,
andareaimedatmeasuringandcontrollingnoise. In(Fangetal., 2003), forex-
ample, anovelstatisticalmodelisproposedfortheanalysisofsystematicerrorsInformation Quality Management Challenges for High-throughput Data 75
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t
a
b
i
l
i
t
y
,
r
e
s
u
l
t
s
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
(
G
e
n
e
r
a
l
)
a
d
e
q
u
a
t
e
p
r
o
c
e
s
s
d
e
s
c
r
i
p
t
i
o
n
p
r
o
v
e
n
a
n
c
e
,
m
e
t
a
-
d
a
t
a
c
a
p
t
u
r
e
s
t
a
n
d
a
r
d
s
a
n
d
t
e
c
h
n
i
q
u
e
s
f
o
r
ﬁ
n
e
-
g
r
a
i
n
p
r
o
c
e
s
s
d
e
s
c
r
i
p
t
i
o
n
(
Z
h
a
o
e
t
a
l
.
,
2
0
0
4
;
G
r
e
e
n
w
o
o
d
e
t
a
l
.
,
2
0
0
3
)
R
a
w
d
a
t
a
(
i
m
-
a
g
e
f
r
o
m
h
y
-
b
r
i
d
i
z
e
d
a
r
r
a
y
)
b
i
o
l
o
g
i
c
a
l
v
a
r
i
a
b
i
l
i
t
y
(
B
a
k
a
y
e
t
a
l
.
,
2
0
0
2
)
t
e
c
h
n
i
c
a
l
v
a
r
i
a
b
i
l
i
t
y
:
c
o
n
s
i
s
t
e
n
c
y
o
f
i
m
a
g
e
q
u
a
l
i
t
y
c
o
n
t
r
o
l
p
a
r
a
m
e
t
e
r
s
r
e
v
i
e
w
:
(
L
e
u
n
g
a
n
d
C
a
v
a
l
i
e
r
i
,
2
0
0
3
;
H
e
s
s
e
t
a
l
.
,
2
0
0
1
)
e
x
p
e
r
i
m
e
n
t
a
l
d
e
s
i
g
n
(
K
e
r
r
a
n
d
C
h
u
r
c
h
i
l
l
,
2
0
0
1
;
D
o
b
b
i
n
a
n
d
S
i
m
o
n
,
2
0
0
5
)
N
o
r
m
a
l
i
z
e
d
d
a
t
a
s
i
g
n
i
ﬁ
c
a
n
c
e
o
f
i
n
t
e
r
p
r
e
t
a
t
i
o
n
g
i
v
e
n
b
i
o
l
o
g
i
c
a
l
a
n
d
t
e
c
h
n
i
c
a
l
v
a
r
i
a
b
i
l
i
t
y
s
e
e
“
s
i
g
n
i
ﬁ
c
a
n
c
e
o
f
d
a
t
a
i
n
t
e
r
p
r
e
t
a
t
i
o
n
”
D
a
t
a
c
o
m
p
a
r
a
b
i
l
i
t
y
(
G
e
n
e
r
a
l
)
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
a
c
r
o
s
s
p
l
a
t
f
o
r
m
s
,
t
e
c
h
n
o
l
o
-
g
i
e
s
,
a
n
d
l
a
b
o
r
a
t
o
r
i
e
s
m
e
t
h
o
d
s
t
o
a
c
c
o
m
m
o
d
a
t
e
v
a
r
i
a
b
i
l
i
t
y
a
c
r
o
s
s
p
l
a
t
f
o
r
m
s
a
n
d
l
a
b
s
(
M
e
m
b
e
r
s
o
f
t
h
e
T
o
x
i
c
o
g
e
n
o
m
i
c
s
R
e
s
e
a
r
c
h
C
o
n
s
o
r
t
i
u
m
,
2
0
0
5
;
L
a
r
k
i
n
e
t
a
l
.
,
2
0
0
5
)
c
o
n
s
i
s
t
e
n
c
y
o
f
r
e
s
u
l
t
s
a
c
r
o
s
s
p
l
a
t
f
o
r
m
s
(
W
a
n
g
e
t
a
l
.
,
2
0
0
5
;
P
e
t
e
r
s
e
n
e
t
a
l
.
,
2
0
0
5
)
S
i
g
n
i
ﬁ
c
a
n
c
e
o
f
d
a
t
a
(
G
e
n
e
r
a
l
)
v
a
r
i
a
b
i
l
i
t
y
c
o
n
t
r
o
l
q
u
a
n
t
i
ﬁ
c
a
t
i
o
n
o
f
m
e
a
s
u
r
e
m
e
n
t
e
r
r
o
r
s
(
H
u
b
e
r
e
t
a
l
.
,
2
0
0
2
)
R
a
w
d
a
t
a
i
m
a
g
e
a
c
c
u
r
a
c
y
:
i
n
t
e
r
p
r
e
t
a
t
i
o
n
o
f
s
p
o
t
s
a
n
d
t
h
e
i
r
i
n
t
e
n
s
i
t
y
l
e
v
e
l
s
,
n
o
n
-
u
n
i
f
o
r
m
h
y
b
r
i
d
i
z
a
-
t
i
o
n
i
m
a
g
e
a
n
a
l
y
s
i
s
a
n
d
q
u
a
l
i
t
y
c
o
n
t
r
o
l
(
L
e
u
n
g
a
n
d
C
a
v
a
l
i
e
r
i
,
2
0
0
3
;
H
e
s
s
e
t
a
l
.
,
2
0
0
1
)
b
a
d
s
p
o
t
d
e
t
e
c
t
i
o
n
,
b
a
c
k
g
r
o
u
n
d
i
d
e
n
t
i
ﬁ
c
a
t
i
o
n
,
i
m
a
g
e
n
o
i
s
e
m
o
d
e
l
l
i
n
g
,
m
a
n
u
a
l
i
n
s
p
e
c
t
i
o
n
o
f
s
p
o
t
s
;
p
o
o
r
i
m
a
g
e
q
u
a
l
i
t
y
m
a
y
r
e
q
u
i
r
e
c
o
s
t
l
y
m
a
n
i
p
u
l
a
t
i
o
n
s
a
n
d
d
e
c
r
e
a
s
e
t
h
e
p
o
w
e
r
o
f
t
h
e
a
n
a
l
y
s
i
s
N
o
r
m
a
l
i
z
e
d
d
a
t
a
c
h
o
i
c
e
o
f
n
o
r
m
a
l
i
z
a
t
i
o
n
a
l
g
o
r
i
t
h
m
s
r
e
v
i
e
w
:
(
L
e
u
n
g
a
n
d
C
a
v
a
l
i
e
r
i
,
2
0
0
3
)
;
c
h
o
o
s
i
n
g
a
n
i
n
a
d
e
q
u
a
t
e
n
o
r
m
a
l
i
z
a
t
i
o
n
a
l
g
o
r
i
t
h
m
m
a
y
l
e
a
d
t
o
a
n
i
n
c
o
m
p
l
e
t
e
r
e
m
o
v
a
l
o
f
s
y
s
t
e
m
a
t
i
c
e
r
r
o
r
s
a
n
d
a
f
f
e
c
t
t
h
e
p
o
w
e
r
o
f
t
h
e
d
o
w
n
s
t
r
e
a
m
a
n
a
l
y
s
i
s
;
l
o
w
-
l
e
v
e
l
d
a
t
a
a
n
a
l
y
s
i
s
(
B
o
l
s
t
a
d
e
t
a
l
.
,
2
0
0
4
)
;
s
t
a
t
i
s
t
i
c
a
l
e
r
r
o
r
a
n
a
l
y
s
i
s
,
d
y
e
-
b
i
a
s
c
o
n
t
r
o
l
a
n
d
r
e
d
u
c
-
t
i
o
n
(
F
a
n
g
e
t
a
l
.
,
2
0
0
3
)
;
a
l
g
o
r
i
t
h
m
s
t
o
c
o
n
t
r
o
l
s
i
g
n
a
l
-
t
o
-
n
o
i
s
e
r
a
t
i
o
s
(
S
e
o
e
t
a
l
.
,
2
0
0
4
)
S
i
g
n
i
ﬁ
c
a
n
c
e
o
f
d
a
t
a
i
n
t
e
r
p
r
e
t
a
t
i
o
n
D
a
t
a
i
n
t
e
r
p
r
e
t
a
t
i
o
n
v
a
l
i
d
i
t
y
o
f
d
a
t
a
a
n
a
l
y
s
i
s
t
e
c
h
n
i
q
u
e
s
a
n
d
t
o
o
l
s
;
r
o
b
u
s
t
n
e
s
s
o
f
a
n
a
l
y
s
i
s
w
i
t
h
r
e
s
p
e
c
t
t
o
v
a
r
i
a
b
i
l
-
i
t
i
e
s
r
e
v
i
e
w
s
o
n
d
e
s
i
g
n
a
n
d
s
e
l
e
c
t
i
o
n
o
f
c
l
u
s
t
e
r
i
n
g
a
l
g
o
r
i
t
h
m
s
:
(
K
a
m
i
n
s
k
i
a
n
d
F
r
i
e
d
m
a
n
,
2
0
0
2
;
L
e
v
e
n
-
s
t
i
e
n
e
t
a
l
.
,
2
0
0
3
)
c
o
m
p
u
t
a
t
i
o
n
a
l
m
e
t
h
o
d
s
t
o
t
a
k
e
v
a
r
i
a
b
i
l
i
t
i
e
s
i
n
t
o
a
c
c
o
u
n
t
(
B
a
k
a
y
e
t
a
l
.
,
2
0
0
2
;
H
a
t
ﬁ
e
l
d
e
t
a
l
.
,
2
0
0
3
)
a
l
g
o
r
i
t
h
m
p
e
r
f
o
r
m
a
n
c
e
a
n
a
l
y
s
i
s
b
y
c
r
o
s
s
-
v
a
l
i
d
a
t
i
o
n
(
P
e
p
e
e
t
a
l
.
,
2
0
0
3
)
i
d
e
n
t
i
ﬁ
c
a
t
i
o
n
o
f
s
i
g
n
i
ﬁ
c
a
n
t
d
i
f
f
e
r
e
n
c
e
s
i
n
g
e
n
e
e
x
p
r
e
s
s
i
o
n
:
s
t
a
t
i
s
t
i
c
a
l
a
n
a
l
y
s
i
s
o
f
r
e
p
l
i
c
a
t
e
d
e
x
p
e
r
-
i
m
e
n
t
s
(
D
u
d
o
i
t
e
t
a
l
.
,
2
0
0
0
)
;
a
n
a
l
y
s
i
s
o
f
t
h
r
e
s
h
o
l
d
c
h
o
i
c
e
t
o
c
h
a
r
a
c
t
e
r
i
s
e
d
i
s
e
a
s
e
v
s
.
n
o
r
m
a
l
i
t
y
(
L
e
u
n
g
a
n
d
C
a
v
a
l
i
e
r
i
,
2
0
0
3
;
P
a
n
e
t
a
l
.
,
2
0
0
5
)
;
u
s
e
o
f
F
a
l
s
e
D
i
s
c
o
v
e
r
y
R
a
t
e
f
o
r
g
e
n
e
r
a
t
i
n
g
g
e
n
e
e
x
p
r
e
s
s
i
o
n
s
c
o
r
e
s
(
P
a
w
i
t
a
n
e
t
a
l
.
,
2
0
0
5
;
R
e
i
n
e
r
e
t
a
l
.
,
2
0
0
3
)
Q
u
a
l
i
t
y
o
f
r
e
f
e
r
e
n
c
e
d
a
t
a
(
G
e
n
e
r
a
l
)
a
c
c
u
r
a
c
y
,
c
o
m
p
l
e
t
e
n
e
s
s
,
s
p
e
c
i
ﬁ
c
i
t
y
,
c
u
r
r
e
n
c
y
o
f
r
e
f
e
r
e
n
c
e
d
a
t
a
b
a
s
e
s
f
u
n
c
t
i
o
n
a
l
a
n
n
o
t
a
t
i
o
n
s
i
n
r
e
f
e
r
e
n
c
e
d
a
t
a
b
a
s
e
s
m
o
s
t
l
y
b
a
s
e
d
o
n
p
r
a
c
t
i
t
i
o
n
e
r
s
’
p
e
r
s
o
n
a
l
p
e
r
c
e
p
t
i
o
n
;
s
y
s
t
e
m
a
t
i
c
s
t
u
d
i
e
s
a
r
e
n
e
e
d
e
d
(
s
e
e
S
e
c
t
i
o
n
3
.
4
i
n
m
a
i
n
t
e
x
t
)
U
n
i
f
o
r
m
i
t
y
o
f
r
e
p
r
e
-
s
e
n
t
a
t
i
o
n
,
r
e
-
u
s
a
b
i
l
i
t
y
o
f
r
e
s
u
l
t
s
O
u
t
p
u
t
d
a
t
a
,
p
u
b
l
i
c
a
t
i
o
n
h
e
t
e
r
o
g
e
n
e
i
t
y
o
f
p
r
e
s
e
n
t
a
t
i
o
n
d
a
t
a
a
n
d
m
e
t
a
-
d
a
t
a
s
t
a
n
d
a
r
d
i
z
a
t
i
o
n
o
f
c
o
n
t
e
n
t
a
n
d
p
r
e
s
e
n
t
a
t
i
o
n
f
o
r
m
a
t
(
L
e
u
n
g
a
n
d
C
a
v
a
l
i
e
r
i
,
2
0
0
3
;
E
d
i
t
o
r
s
,
2
0
0
2
)
(
s
e
e
a
l
s
o
S
e
c
t
i
o
n
4
i
n
m
a
i
n
t
e
x
t
)76 DATABASE MODELING IN BIOLOGY: PRACTICES AND CHALLENGES
T
a
b
l
e
4
.
3
.
Q
u
a
l
i
t
y
i
s
s
u
e
s
i
n
p
r
o
t
e
i
n
i
d
e
n
t
i
ﬁ
c
a
t
i
o
n
e
x
p
e
r
i
m
e
n
t
s
C
o
m
m
o
n
q
u
a
l
i
t
y
i
s
s
u
e
s
A
r
t
i
f
a
c
t
S
p
e
c
i
ﬁ
c
i
s
s
u
e
s
E
x
a
m
p
l
e
s
,
t
e
c
h
n
i
q
u
e
s
a
n
d
r
e
f
e
r
e
n
c
e
s
Q
u
a
l
i
t
y
o
f
s
a
m
p
l
e
B
i
o
l
o
g
i
c
a
l
a
s
s
a
y
b
i
o
l
o
g
i
c
a
l
v
a
r
i
a
b
i
l
i
t
y
,
c
o
n
t
a
m
i
n
a
t
i
o
n
c
o
n
t
r
o
l
s
a
m
p
l
e
c
o
n
t
a
m
i
n
a
t
i
o
n
w
i
t
h
,
e
.
g
.
,
h
u
m
a
n
p
r
o
t
e
i
n
s
f
r
o
m
t
h
e
e
x
p
e
r
i
m
e
n
t
e
r
m
a
y
o
b
s
c
u
r
e
t
h
e
r
e
s
u
l
t
s
o
f
d
o
w
n
s
t
r
e
a
m
a
n
a
l
y
s
i
s
P
r
o
c
e
s
s
r
e
p
e
a
t
a
b
i
l
i
t
y
,
r
e
s
u
l
t
s
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
(
G
e
n
e
r
a
l
)
a
d
e
q
u
a
t
e
p
r
o
c
e
s
s
d
e
s
c
r
i
p
t
i
o
n
d
a
t
a
m
o
d
e
l
l
i
n
g
f
o
r
c
a
p
t
u
r
i
n
g
e
x
p
e
r
i
m
e
n
t
d
e
s
i
g
n
a
n
d
e
x
e
c
u
t
i
o
n
r
e
s
u
l
t
s
(
F
e
n
y
o
e
a
n
d
B
e
a
v
i
s
,
2
0
0
2
)
t
h
e
P
E
D
R
O
d
a
t
a
m
o
d
e
l
(
T
a
y
l
o
r
e
t
a
l
.
,
2
0
0
3
)
s
e
e
a
l
s
o
u
n
i
f
o
r
m
i
t
y
,
b
e
l
o
w
R
a
w
d
a
t
a
(
m
a
s
s
s
p
e
c
t
r
a
)
t
e
c
h
n
i
c
a
l
a
n
d
b
i
o
l
o
g
i
c
a
l
v
a
r
i
a
b
i
l
i
t
y
a
n
a
l
y
s
i
s
o
f
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
(
S
t
e
w
a
r
t
e
t
a
l
.
,
2
0
0
4
)
q
u
a
n
t
i
t
a
t
i
v
e
a
s
s
e
s
s
m
e
n
t
o
f
v
a
r
i
a
b
i
l
i
t
y
(
C
h
a
l
l
a
p
a
l
l
i
e
t
a
l
.
,
2
0
0
4
)
D
a
t
a
c
o
m
p
a
r
a
b
i
l
i
t
y
(
G
e
n
e
r
a
l
)
r
e
p
r
o
d
u
c
i
b
i
l
i
t
y
a
c
r
o
s
s
p
l
a
t
f
o
r
m
s
,
t
e
c
h
-
n
o
l
o
g
i
e
s
,
a
n
d
l
a
b
o
r
a
t
o
r
i
e
s
r
e
v
i
e
w
:
(
H
a
n
c
o
c
k
e
t
a
l
.
,
2
0
0
2
)
S
i
g
n
i
ﬁ
c
a
n
c
e
o
f
d
a
t
a
(
G
e
n
e
r
a
l
)
v
a
r
i
a
b
i
l
i
t
y
c
o
n
t
r
o
l
r
e
v
i
e
w
o
n
s
t
a
t
i
s
t
i
c
a
l
a
n
d
c
o
m
p
u
t
a
t
i
o
n
a
l
i
s
s
u
e
s
a
c
r
o
s
s
a
l
l
p
h
a
s
e
s
o
f
d
a
t
a
a
n
a
l
y
s
i
s
(
(
L
i
s
t
g
a
r
t
e
n
a
n
d
E
m
i
l
i
,
2
0
0
5
)
)
r
e
v
i
e
w
o
n
a
n
a
l
y
s
i
s
o
f
s
e
n
s
i
t
i
v
i
t
y
(
S
m
i
t
h
,
2
0
0
2
)
R
a
w
d
a
t
a
(
m
a
s
s
s
p
e
c
t
r
a
)
s
e
n
s
i
t
i
v
i
t
y
o
f
s
p
e
c
t
r
a
g
e
n
e
r
a
t
i
o
n
m
e
t
h
-
o
d
s
,
d
y
n
a
m
i
c
r
a
n
g
e
f
o
r
r
e
l
a
t
i
v
e
p
r
o
t
e
i
n
a
b
u
n
d
a
n
c
e
t
e
c
h
n
i
c
a
l
a
n
d
b
i
o
l
o
g
i
c
a
l
v
a
r
i
a
b
i
l
i
t
y
l
i
m
i
t
a
t
i
o
n
s
o
f
t
e
c
h
n
o
l
o
g
y
f
o
r
g
e
n
e
r
a
t
i
n
g
s
p
e
c
t
r
a
r
e
v
i
e
w
o
n
s
t
r
a
t
e
g
i
e
s
t
o
i
m
p
r
o
v
e
a
c
c
u
r
a
c
y
a
n
d
s
e
n
s
i
t
i
v
i
t
y
o
f
P
I
,
q
u
a
n
t
i
ﬁ
c
a
t
i
o
n
o
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in microarray experiments. Here, errors that lead to low accuracy are detected
and corrected by introducing different normalization techniques, whose effec-
tiveness is compared experimentally; different statistical models are applied
depending on the speciﬁc microarray experiment design used.
Information quality practitioners will probably be on more familiar ground
when quality concepts like accuracy, currency, and timeliness are applied to
reference databases used in the experiments, e.g., for protein-peptide matches,
or to the last phase of our reference pipeline, when the differently expressed
genes in a transcriptome experiment are functionally annotated. In this case,
“accuracy” refers to the likelihood that a functional annotation is correct, i.e.,
that the description of the function of the gene or gene product corresponds to
its real function4. As mentioned, annotations may be done either by human
experts, basedonpublicationsevidence, orautomaticallybyalgorithmsthattry
to infer function from structure and their similarity with that of other known
gene products. In the ﬁrst case, measuring accuracy amounts to supporting or
disproving scientiﬁc claims made in published literature, while in the second,
the predictive performance of an algorithm is measured.
In general, we observe a trade-off between the accuracy of curator-produced
functional annotations, which have a low throughput, and the timeliness of
the annotation, i.e., how soon the annotation becomes available after the gene
productissubmittedtoadatabase. AnotableexampleisprovidedbytheSwiss-
Prot and TrEMBL protein databases. While in the former, annotations are
done by biologists, with great accuracy at the expense of timeliness, TrEMBL
contains proteins that are automatically annotated, often with lower accuracy,
but are made available sooner (Junker et al., 2000). This gives the scientist
a choice, based on personal requirements. For well-curated database such as
UniProt, claims of non-redundancy (but not of completeness) are also made
(O’Donovan et al., 1999).
3.4 Beyond data generation: annotation and presentation
To conclude this section, we now elaborate further on the topic of func-
tional annotations and their relationship to quality. The aim of annotation is, in
general, to “bridge the gap between the sequence and the biology of the organ-
ism” (Stein, 2001). In this endeavour, three main layers of interpretation of the
raw data are identiﬁed: nucleotide-level (where are the genes in a sequence?),
protein-level (what is the function of a protein?), and process-level (what is the
role of genes and proteins in the biological process? how do they interact?).
The information provided by high-throughput transcriptomics and proteomics
contributes to functional and process annotation. Thus, it participates in the
cycle shown in Figure 4.3: publications are used by curators to produce func-
tional annotations on protein database entries, which in turn may stimulate the78 DATABASE MODELING IN BIOLOGY: PRACTICES AND CHALLENGES
proposalofnewexperiments(automaticannotationsuseinformationfromother
databases, as well).
Figure 4.3. The annotation process
Although a bit simplistic, this view is sufﬁcient to identify the critical is-
sue with annotation: erroneous functional annotation based on biased results
and conclusions due to unaccounted variabilities in experiments can propagate
through public databases and further lead to wrong conclusions.
Most of the studies on the percolation effects of annotation errors have fo-
cused on automated annotations, in which protein function is determined com-
putationally, based on sequence similarity to other proteins in the same domain
(Karp et al., 2001; Gilks et al., 2002; Devos and Valencia, 2001; Wieser et al.,
2004; Prlic et al., 2004). However, the issue of validating curated annotations
that are based on published literature is more subtle. One approach is based on
the observation that, when standard controlled vocabularies are used for anno-
tation, the consistency of use of the terminology offered by these vocabularies
inmultipleindependentannotationsofthesamedatacanbeusedasanindicator
of annotation accuracy.
Asanexample,considertheGeneOntology(GO),awell-knownstandardon-
tologyfordescribingthefunctionofeukaryoticgenes(Consortium, 2000). GO
is maintained by a consortium of three model organism databases, and consists
of three parts: molecular function, biological process and cellular component
(the sub-cellular structures where they are located). Up to the present, GO an-
notations have been used to annotate almost two million gene products in more
than 30 databases. UniProt is the most prominent, accounting for almost 50%
of the annotations.
Theadoptionofsuchastandardinbiologyhasallowedresearcherstoinvesti-
gate issues of annotation consistency. We mention two contributions here. The
ﬁrst (Lord et al., 2003) has studied measures of semantic similarity between
SwissProtentries, basedontheirGOannotations. Theauthorshypothesizethat
valid conclusions about protein similarity can be drawn not only based on their
sequence similarity (as would be done for instance by BLAST), but also from
the semantic similarity of the annotations that describe the biological role of
the proteins. The latter is described by metric functions deﬁned on the GOInformation Quality Management Challenges for High-throughput Data 79
structure (GO is a directed acyclic graph). Based on statistical evidence, the
authors conclude that the hypothesis is valid for various speciﬁc assumptions,
e.g., that the data set is restricted to those proteins whose annotations are sup-
ported by published literature, as opposed to being inferred from some indirect
data source.
The second contribution has studied the consistency of annotations among
orthologues in different databases5 (Dolan et al., 2005). Experiments on sets
of mouse and human proteins resulted in a useful classiﬁcation of annotation
errors and mismatches, and in effective techniques for their detection.
These studies offer a partial, but quantitative validation of the main claim
that standardization of terminology improves the conﬁdence in the annotation
process and facilitates the retrieval of information.
4. CURRENT APPROACHES TO QUALITY:
META-DATA COLLECTION, STANDARDIZATION,
VOCABULARIES
Partly to dominate the complexity of the domain and the broad variabil-
ity of available techniques, the information management community has been
adopting a general approach towards standardization based on (i) modelling,
capturing and exploiting meta-data that describes the experimental processes
in detail, known as provenance; and (ii) creating controlled vocabularies and
ontologies used to describe the meta-data.
Information quality management may beneﬁt greatly from this approach.
4.1 Modelling, collection and use of provenance meta-data
Throughout this chapter, we have mentioned a number of variability fac-
tors that affect the outcome of an experiment. The meta-information about
these variables and their impact, i.e., the experimental design and details of
experiment execution, is known as provenance. The importance of capturing
provenance in a formal and machine-processable way has been recognized in
the recent past, as a way to promote interoperability and uniformity across
labs. The role of provenance in addressing quality issues, however, has not
yet been properly formalized. Recent research efforts have been focusing on
using provenance and other types of meta-data, to allow scientists to formally
express quality preferences, i.e., to deﬁne decision procedures for selecting or
discarding data based on underlying quality indicators (Missier et al., 2005).
Standardsforcapturingprovenancearebeginningtoemerge, butmuchwork
is still to be done. Within the transcriptomic community, one initial response
comes from the Microarray Gene Expression Data (MGED) society, which has
proposed a standard set of guidelines called MIAME (Brazma et al., 2001),
for Minimal Information About a Microarray Experiment, prescribing minimal80 DATABASE MODELING IN BIOLOGY: PRACTICES AND CHALLENGES
content for an acceptable database submission. Along with content standard-
ization, the Microarray and Gene Expression (MAGE) group within MGED in
collaboration with the Object Management Group (OMG) also deﬁnes MAGE-
OM, an object model describing the conceptual structure of MIAME docu-
ments. The model has been mapped to MAGE-ML, an XML markup language
for writing MAGE-OM documents, resulting in a complete standard for the
preparation of MIAME-compliant database submissions.
Furthermore, MAGE prescribes that experiment descriptions be annotated
using the MGED ontology, a controlled vocabulary for the gene expression
domain. MGED is currently being redesigned, with the goal of encompassing
a broader domain of functional genomics, and will hopefully include a struc-
ture and terminology for experimental variables, which is currently missing.
Writing complete MAGE-ML documents is a lengthy process for non-trivial
experiments. At present, adoption of the standard by the research community
is driven mostly by the requirement that data submitted to major journals for
publication be MIAME-compliant.
Similar efforts are under way in the proteomic ﬁeld (Orchard et al., 2003),
although accepted standards do not yet exist for data models and format (al-
though some proposed data models like PEDRo are being increasingly adopted
bythecommunity(Garwoodetal., 2004)). TheHumanProteomeOrganisation
(HUPO) provides updated information on its Proteomics Standards Initiative
(PSI).
The challenge for these standardization efforts is the rapid development of
functional genomics. This requires these standards to be speciﬁc enough to
capture all the details of the experiments but at the same time to be generic and
ﬂexible enough to adapt and be extended to changes in existing or evolving
of new experimental techniques. Furthermore, these standards need to cater
for different communities within the large and diverse biological community.
Examplesofthisdiversityincludethestudyofeukaryotesorprokaryotes,model
organismsthathavealreadybeensequencedornon-modelorganismswithonly
limited amount of information available, inbred populations that can be studied
in controlled environment or outbred populations that can only be studied in
their natural environment6.
To allow a systems biology approach to the analysis of data from different
kinds of experiments, a further effort is undertaken by a number of standard-
ization bodies to create a general standard for functional genomics (FuGE)7.
This effort is based on the independent standards for transcriptomics and pro-
teomicsmentionedaboveandseekstomodelthecommonaspectsoffunctional
genomics experiments.
One of the practical issues with provenance data is that, in the wet lab,
the data capture activity represents additional workload for the experimenter,
possiblyassistedbytheequipmentsoftware. TheadvantageinthedrylabisthatInformation Quality Management Challenges for High-throughput Data 81
extensiveinformationsystemsupportduringexperimentexecutionisavailable,
in particular based on workﬂow technology, as proven in the myGrid project
(Zhao et al., 2004; Greenwood et al., 2003). In this case, provenance can be
captured by detailed journaling of the workﬂow execution.
4.2 Creating controlled vocabularies and ontologies
The second approach for a standardized representation of data and meta-
data is the development of controlled vocabularies and ontologies. A large
number of ontologies is being developed, including ontologies to represent
aspects of functional genomics experiments, such as the MGED ontology for
transcriptomics8 or the PSI ontology for proteomics9, both of which will form
part of the Functional Genomics Ontology (FuGO, part of FuGE).
As for the development of standardized models for meta-data, the develop-
ment of standardized controlled vocabulary faces similar challenges, such as
the rapid development of the technologies that are described in the ontology or
theknowledgepresentedinacontrolledvocabulary. Furthermore,therepresen-
tationoftheontologiesvaries, rangingfromlistsoftermstocomplexstructures
modeled using an ontology language, such as OWL10.
5. CONCLUSIONS
We have presented a survey on quality issues that biologists face during the
execution of transcriptomics and proteomics experiments, and observed that
issues of poor quality in published data can be traced to the complexity of
controlling the biological and technical variables within the experiment.
Ouranalysissuggeststhat, despitetheirdifferences, acommonstructureand
a common set of quality issues for the two classes of experiments can be found;
we have proposed a framework for the classiﬁcation of these issues, and used
it to survey current quality control techniques.
We argued that the scientists’ ability to make informed decisions regarding
the quality of published data relies on the availability of meta-information de-
scribing the experiment variables, as well as on standardization efforts on the
content and structure of meta-data.
The area of information management can play a major role in this efforts, by
providing suitable information management models for meta-data, and tools to
exploit it. Although the literature offers many more results on these topics that
canbepresentedhere,wehaveofferedastartingpointforin-depthinvestigation
of this ﬁeld.
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NOTES
1 The term “information” is often used in contrast with “data”, to underline the difference
between the ability to establish formal correctness of a data item, and the ability to provide
a correct interepretation for it. In this sense, assessing reliability is clearly a problem of
correct interpretation, hence of information quality.
2 The term gene expression refers to the process of DNA transcription for protein produc-
tion within a cell. For a general introduction to the topics of genomic and proteomics,
see (Campbell and Heyer, 2003).
3 For a tutorial on microarrays, see
http://www.ncbi.nlm.nih.gov/About/primer/microarrays.html.
4 Assessing the completeness of an annotation is just as important; however, the intrinsic
incompleteness of the biological interpretation of genes and gene products (King et al.,
2003) makes this task even more challenging.
5 Orthologues are similar genes that occur in the genomes of different species.
6 See, e.g., http://envgen.nox.ac.uk/miame/miame env.html for a proposal to extend the MI-
AMEstandardtotakeintoaccountrequirementsoftheenvironmentalgenomicscommunity.
7 http://fuge.sourceforge.net/ and http://sourceforge.net/projects/fuge/
8 http://mged.sourceforge.net/ontologies/
9 http://psidev.sourceforge.net/ontology/
10 http://www.w3.org/TR/owl-features/
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